Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin in High-Risk Pediatric Hyperlipidaemia
2011-004964-32Phase 3Completed
- Sponsor
- Kowa Research Europe
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pitavastatin in hyperlipidemia (4 arms), sponsored by Kowa Research Europe. Primary endpoint: Percent change in LDL-C from baseline to Week 12 endpoint. Started Feb 2012; status: completed.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on 2011-004964-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004964-32.